FR13C0008I2 - Derives de phosphonocephem, leur procede de preparation et leur utilisation - Google Patents
Derives de phosphonocephem, leur procede de preparation et leur utilisationInfo
- Publication number
- FR13C0008I2 FR13C0008I2 FR13C0008C FR13C0008C FR13C0008I2 FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2 FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2
- Authority
- FR
- France
- Prior art keywords
- preparation process
- phosphonocephem
- derivatives
- phosphonocephem derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JKKCZQKHMGGMQT-LWOQYNTDSA-N P(=O)(O)(O)C1S[C@H]2N(C=C1)C(C2)=O Chemical class P(=O)(O)(O)C1S[C@H]2N(C=C1)C(C2)=O JKKCZQKHMGGMQT-LWOQYNTDSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35149997 | 1997-12-19 | ||
PCT/JP1998/005709 WO1999032497A1 (fr) | 1997-12-19 | 1998-12-17 | Derives de phosphonocephem, leur procede de preparation et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR13C0008I1 FR13C0008I1 (nl) | 2013-03-22 |
FR13C0008I2 true FR13C0008I2 (fr) | 2013-08-16 |
Family
ID=18417716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR13C0008C Active FR13C0008I2 (fr) | 1997-12-19 | 2013-02-06 | Derives de phosphonocephem, leur procede de preparation et leur utilisation |
Country Status (19)
Country | Link |
---|---|
US (1) | US6417175B1 (nl) |
EP (2) | EP1043327B1 (nl) |
JP (3) | JP3467418B2 (nl) |
KR (1) | KR100384047B1 (nl) |
CN (2) | CN1194980C (nl) |
AT (1) | ATE430155T1 (nl) |
AU (1) | AU1683299A (nl) |
BE (1) | BE2013C004I2 (nl) |
CA (1) | CA2314564C (nl) |
CY (2) | CY1109276T1 (nl) |
DE (1) | DE69840796D1 (nl) |
DK (1) | DK1043327T3 (nl) |
ES (1) | ES2325139T3 (nl) |
FR (1) | FR13C0008I2 (nl) |
LU (1) | LU92134I2 (nl) |
NL (1) | NL300568I1 (nl) |
PT (1) | PT1043327E (nl) |
TW (1) | TW473479B (nl) |
WO (1) | WO1999032497A1 (nl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2323759T3 (es) * | 2000-08-10 | 2009-07-24 | Takeda Pharmaceutical Company Limited | Compuesto de fosfonocefem. |
US20070249577A1 (en) * | 2005-05-10 | 2007-10-25 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
US20070238719A1 (en) * | 2005-05-10 | 2007-10-11 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
US20070238720A1 (en) * | 2005-05-10 | 2007-10-11 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
CN101357929B (zh) * | 2007-06-22 | 2010-12-15 | 山东轩竹医药科技有限公司 | 含有巯基噻二唑的头孢菌素衍生物 |
US20090082326A1 (en) | 2007-09-21 | 2009-03-26 | Forest Laboratories Holdings Limited | Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
US20100197650A1 (en) | 2008-08-28 | 2010-08-05 | Forest Laboratories Holdings Ltd. | Compositions and methods of treatment comprising ceftaroline |
US8247400B2 (en) * | 2009-02-23 | 2012-08-21 | Dedhiya Mahendra G | Cephem compounds useful for the treatment of bacterial infections |
MX2012003201A (es) | 2009-09-21 | 2012-05-08 | Astrazeneca Ab | Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina. |
FR2951171A1 (fr) * | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
RU2769076C2 (ru) | 2011-06-17 | 2022-03-28 | Пфайзер Анти-Инфективз Аб | Способ получения гетероциклических соединений, включая транс-7-оксо-6-(сульфокси)-1,6-диазабицикло[3.2.1]октан-2-карбоксамид и его соли |
EP2788361A1 (en) | 2011-12-07 | 2014-10-15 | Ranbaxy Laboratories Limited | Process for preparing ceftaroline salts or hydrates thereof |
US9481698B2 (en) | 2012-10-19 | 2016-11-01 | Sandoz Ag | Process for preparing ceftaroline fosamil |
CN102977124B (zh) * | 2012-12-13 | 2014-11-26 | 山东诚创医药技术开发有限公司 | 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法 |
CN104870457B (zh) * | 2012-12-20 | 2017-08-08 | 桑多斯股份公司 | 头孢洛林酯的新晶形 |
KR102428252B1 (ko) | 2014-02-21 | 2022-08-02 | 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 | 치료적 투여용 수용성 o-카보닐 포스포르아미데이트 전구약물 |
CN106565784B (zh) * | 2016-10-31 | 2019-02-26 | 瑞阳制药有限公司 | 头孢洛林酯二钠盐的纯化方法 |
CN110872322B (zh) * | 2018-08-29 | 2022-08-02 | 上海博志研新药物技术有限公司 | 乙酸头孢罗膦一水合物及其中间体的制备方法 |
CN113072567B (zh) * | 2021-03-26 | 2022-10-14 | 海南海灵化学制药有限公司 | 一种拉氧头孢钠合成工艺 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5941999B2 (ja) * | 1975-07-24 | 1984-10-11 | 武田薬品工業株式会社 | セフエムまたはベナム化合物の製造法 |
JPS5511600A (en) | 1978-07-10 | 1980-01-26 | Fujisawa Pharmaceut Co Ltd | Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same |
US4268509A (en) * | 1978-07-10 | 1981-05-19 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and processes for preparation thereof |
FR2511372A1 (fr) | 1981-08-17 | 1983-02-18 | Rhone Poulenc Sante | Nouveaux derives de la cephalosporine et leur preparation |
JPS5931791A (ja) * | 1982-07-19 | 1984-02-20 | Fujisawa Pharmaceut Co Ltd | 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤 |
US4563449A (en) | 1982-07-19 | 1986-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
JPS62238291A (ja) * | 1986-04-10 | 1987-10-19 | Fujisawa Pharmaceut Co Ltd | セフエム化合物および医薬として許容されるその塩 |
US4978663A (en) | 1989-08-16 | 1990-12-18 | Hoechst-Roussel Pharmaceuticals Inc. | 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility |
JP3514495B2 (ja) | 1992-10-02 | 2004-03-31 | エーザイ株式会社 | ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法 |
JP3927262B2 (ja) * | 1995-07-19 | 2007-06-06 | 武田薬品工業株式会社 | セフェム化合物、その製造法および抗菌組成物 |
JPH10265488A (ja) * | 1997-03-27 | 1998-10-06 | Takeda Chem Ind Ltd | ホスフォノセフェム誘導体 |
-
1998
- 1998-12-02 TW TW087119933A patent/TW473479B/zh not_active IP Right Cessation
- 1998-12-17 DE DE69840796T patent/DE69840796D1/de not_active Expired - Lifetime
- 1998-12-17 CN CNB988122944A patent/CN1194980C/zh not_active Expired - Lifetime
- 1998-12-17 ES ES98961385T patent/ES2325139T3/es not_active Expired - Lifetime
- 1998-12-17 US US09/555,949 patent/US6417175B1/en not_active Expired - Lifetime
- 1998-12-17 KR KR10-2000-7006796A patent/KR100384047B1/ko not_active IP Right Cessation
- 1998-12-17 CA CA002314564A patent/CA2314564C/en not_active Expired - Lifetime
- 1998-12-17 AT AT98961385T patent/ATE430155T1/de active
- 1998-12-17 JP JP35888798A patent/JP3467418B2/ja not_active Expired - Lifetime
- 1998-12-17 WO PCT/JP1998/005709 patent/WO1999032497A1/ja active IP Right Grant
- 1998-12-17 AU AU16832/99A patent/AU1683299A/en not_active Abandoned
- 1998-12-17 EP EP98961385A patent/EP1043327B1/en not_active Expired - Lifetime
- 1998-12-17 EP EP09158866A patent/EP2080765A1/en not_active Withdrawn
- 1998-12-17 PT PT98961385T patent/PT1043327E/pt unknown
- 1998-12-17 DK DK98961385T patent/DK1043327T3/da active
- 1998-12-17 CN CN2005100079635A patent/CN1679595B/zh not_active Expired - Lifetime
-
2000
- 2000-07-04 JP JP2000206824A patent/JP2001048893A/ja active Pending
-
2009
- 2009-01-16 JP JP2009007750A patent/JP2009114202A/ja not_active Abandoned
- 2009-07-29 CY CY20091100809T patent/CY1109276T1/el unknown
-
2013
- 2013-01-07 CY CY2013003C patent/CY2013003I2/el unknown
- 2013-01-08 BE BE2013C004C patent/BE2013C004I2/fr unknown
- 2013-01-11 NL NL300568C patent/NL300568I1/nl unknown
- 2013-01-16 LU LU92134C patent/LU92134I2/fr unknown
- 2013-02-06 FR FR13C0008C patent/FR13C0008I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
JP2001048893A (ja) | 2001-02-20 |
CN1194980C (zh) | 2005-03-30 |
CA2314564A1 (en) | 1999-07-01 |
JPH11255772A (ja) | 1999-09-21 |
JP2009114202A (ja) | 2009-05-28 |
DK1043327T3 (da) | 2009-08-17 |
KR20010015885A (ko) | 2001-02-26 |
FR13C0008I1 (nl) | 2013-03-22 |
NL300568I2 (nl) | 2016-01-18 |
CY2013003I2 (el) | 2015-08-05 |
NL300568I1 (nl) | 2016-01-18 |
ES2325139T3 (es) | 2009-08-26 |
TW473479B (en) | 2002-01-21 |
CN1679595B (zh) | 2010-05-12 |
US6417175B1 (en) | 2002-07-09 |
CA2314564C (en) | 2008-11-18 |
EP1043327A4 (en) | 2001-12-12 |
ATE430155T1 (de) | 2009-05-15 |
WO1999032497A1 (fr) | 1999-07-01 |
CY2013003I1 (el) | 2014-07-02 |
LU92134I2 (fr) | 2013-03-18 |
JP3467418B2 (ja) | 2003-11-17 |
EP1043327A1 (en) | 2000-10-11 |
CN1282335A (zh) | 2001-01-31 |
CN1679595A (zh) | 2005-10-12 |
EP2080765A1 (en) | 2009-07-22 |
EP1043327B1 (en) | 2009-04-29 |
DE69840796D1 (de) | 2009-06-10 |
AU1683299A (en) | 1999-07-12 |
CY1109276T1 (el) | 2014-07-02 |
BE2013C004I2 (en) | 2018-01-29 |
KR100384047B1 (ko) | 2003-05-14 |
PT1043327E (pt) | 2009-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR13C0008I2 (fr) | Derives de phosphonocephem, leur procede de preparation et leur utilisation | |
FR2784107B1 (fr) | Microfibrilles de cellulose a surface modifiee, leur procede de preparation, et leur utilisation | |
FR2732680B1 (fr) | Composes de type ceramides, leur procede de preparation et leur utilisation | |
PT901474E (pt) | Derivados de aril-pirimidina. | |
EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
FR2660556B1 (fr) | Microspheres, leur procede de preparation et leur utilisation. | |
EE9800265A (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena | |
EE04721B1 (et) | Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine | |
EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
NO975977L (no) | Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav | |
PT922050E (pt) | Derivados de 3-descladinose-2,3-anidroeritromicina | |
FR2680506B1 (fr) | Procede de preparation de derives de la beta-phenylisoserine et leur utilisation. | |
NO960499D0 (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
PT931087E (pt) | Novos derivados de piranosido | |
MA24472A1 (fr) | Procede | |
MA24470A1 (fr) | Procede | |
FR2755439B1 (fr) | Derives aryloxypropanolamines, leur procede de preparation et leurs applications | |
GR3035834T3 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
MA26590A1 (fr) | Derives de thiazole, leur procede de preparation et leur utilisation. | |
FR2765874B1 (fr) | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique | |
ZA9810403B (en) | New epothilon derivatives, process for their preparation and their pharmaceutical use. | |
BR9701404A (pt) | Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol | |
DE69711853T2 (de) | Pyridincarboxamid-derivate | |
FR2725450B1 (fr) | Aminoplastes, procede pour leur preparation et leur utilisation | |
FR2769627B1 (fr) | Derives de (3-oxoisoindoline-1-ylidine) propanedinitrile et leur procede de preparation |